Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Byrne

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Clinical Hematology International|October 1, 2021
Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid LeukemiaKatie Culos, Michael Byrne
Current Hematologic Malignancy Reports|March 4, 2020
Indications for Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic SyndromeNathalie Danielson, Michael Byrne
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Imaging, staging and response evaluationMichael Byrne, Gunnar Hillerdal
The Oncologist|October 9, 2015
Hope Is PalliativeJulie Byrne, Michael Byrne
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2016
Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host DiseaseMichael Byrne, Bipin N Savani
Current Opinion in Hematology|September 17, 2021
Detecting and preventing post-hematopoietic cell transplant relapse in AMLAnne E Austin, Michael Byrne
Journal of Mental Health (Abingdon, England)|January 25, 2013
Psychometric properties of a Mental Health Team Development Audit ToolSilvia Roncalli, Michael Byrne, Steve Onyett
American Journal of Clinical Oncology|May 2, 2012
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacyBassam Estfan, Michael Byrne, Richard Kim
British Journal of Haematology|September 13, 2021
Treosulphan versus busulphan: pros and consPritesh Patel, Bipin Savani, Michael Byrne
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Improving the OddsMichael Byrne, Bipin Savani, Edward Copelan
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Clinical Hematology International|October 1, 2021
Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid LeukemiaKatie Culos, Michael Byrne
Current Hematologic Malignancy Reports|March 4, 2020
Indications for Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic SyndromeNathalie Danielson, Michael Byrne
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Imaging, staging and response evaluationMichael Byrne, Gunnar Hillerdal
The Oncologist|October 9, 2015
Hope Is PalliativeJulie Byrne, Michael Byrne
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2016
Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host DiseaseMichael Byrne, Bipin N Savani
Current Opinion in Hematology|September 17, 2021
Detecting and preventing post-hematopoietic cell transplant relapse in AMLAnne E Austin, Michael Byrne
Journal of Mental Health (Abingdon, England)|January 25, 2013
Psychometric properties of a Mental Health Team Development Audit ToolSilvia Roncalli, Michael Byrne, Steve Onyett
American Journal of Clinical Oncology|May 2, 2012
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacyBassam Estfan, Michael Byrne, Richard Kim
British Journal of Haematology|September 13, 2021
Treosulphan versus busulphan: pros and consPritesh Patel, Bipin Savani, Michael Byrne
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Improving the OddsMichael Byrne, Bipin Savani, Edward Copelan
Pageof 15